The CDC website now claims "studies supporting a link [between vaccines and autism] have been ignored by health authorities."
Joshua Fitch
Advertisement
Articles by Joshua Fitch
Upadacitinib (15 and 30 mg) was evaluated in adolescents with moderate to severe AD aged 12 to 17 years, with and without topical corticosteroids.
Immunization Awareness Month
The ACIP was unanimous in its recommendation for routine use of nirsevimab-alip to prevent RSV LRTD in newborns and young infants during their first RSV season.
FDA approval of the monoclonal antibody against RSV follows the unanimous vote from the agency's Antimicrobial Drugs Advisory Committee.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Patient Care Online
1
Centanafadine XR Meets Phase 3b ADHD Endpoint in Adults With Comorbid Anxiety
2
Social Determinants May Improve Disease Risk Prediction Beyond Genetics Alone
3
Tirzepatide and Emerging OSA Pharmacotherapy Expand the Treatment Toolkit, With Ashesha Mechineni, MD
4
OSA Treatment Beyond CPAP: Tirzepatide, Phenotyping, and What's Next, With Ashesha Mechineni, MD
5